Societies Collaborate to Address Differentiated Thyroid Cancer

March 22, 2018

At the Multilateral Conference on Differentiated Thyroid Cancer held in Martinique in January, representatives of SNMMI, the European Association of Nuclear Medicine (EANM), the European Thyroid Association (ETA) and American Thyroid Association (ATA) discussed issues related to the care of patients with thyroid cancer, with particular focus on radioactive iodine (RAI) therapy.

Over two days of presentations, debate and discussion, moderated by Laszlo Hegedüs, MD, they addressed

  • formalizing dialogue and activities between the four societies,
  • indications and optimal prescribed activity for RAI adjuvant therapy, and
  • definition and classification of radioiodine refractory thyroid cancer.

The group synthesized the proceedings into what are being called the “Martinique Principles," which consist of the major points that the attendees agreed upon and also define terminology and outline areas of controversy and goals for future study. Next on the agenda is a white paper, which the group plans to submit to the ATA’s journal, Thyroid, with possible editorials published in The Journal of Nuclear Medicine, European Journal of Nuclear Medicine, and European Thyroid Journal.

Looking ahead, the group sees the value of ongoing collaboration and hopes to have a formal framework established to support additional meetings.

Link to the societies' joint letter